Myopia Control

Articles discussing a Cyclogyl shortage and an FDA orphan drug designation for a retinitis pigmentosa treatment lead Healio/OSN coverage so far in August.

Johnson & Johnson Vision announced that the FDA approved Acuvue Abiliti Overnight orthokeratology contact lenses, designed to help manage myopia.

Johnson & Johnson introduced Acuvue Abiliti, a brand focused on creating products and services to help parents and eye care providers address the growing number of childhood myopia cases.

The World Council of Optometry’s board of directors passed a resolution advising myopia management, mitigation and measurement to be incorporated as a standard of care for optometrists.

CooperVision has partnered with the American Academy of Ophthalmology and the World Council of Optometry to address worldwide myopia and promote a standard of care for the disease, the company announced in recent press releases.

The World Council of Optometry announced that it will continue its relationship with WHO into 2023, with an objective to “promote policies and strategies derived from the decisions of governing bodies” of WHO.

A 6-year clinical trial of 114 children between the ages of 8 and 12 years confirmed the safety of daily disposable hydrogel contact lenses and identified slowed progression of myopia in children who wore CooperVision’s MiSight lenses.

CooperCompanies and EssilorLuxottica announced a partnership to accelerate commercialization of SightGlass Vision spectacle lenses, which are designed to slow the progression of myopia in children, according to press releases from the companies.

Kubota Vision Inc. announced it completed a myopia control wearable prototype based on Kubota Glasses technology.

Researchers found low complication rates in children wearing soft contact lenses for myopia management, according to a study published in Ophthalmic & Physiological Optics.